Yes, I'm also surprised by the muted response to the latest massive contract.
A contract that doubled ARR like that!
To me it makes it clear that the market want to see FDA and an Australian contract as further validators. Once they happen then IME will be given a more respectable multiple.
Ann: Quarterly Cash Flow and Summary of Activities, page-36
Add IME (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.04M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4825 | 41.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 43.0¢ | 20000 | 1 |
View Market Depth
| Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
| IME (ASX) Chart |
Day chart unavailable